Park West Asset Management LLC Celcuity Inc. Transaction History

Park West Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$16.13 - $26.99 $1.3 Million - $2.17 Million	-80,419 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.55 - $21.3 $286,230 - $449,941	-21,124 Reduced 20.8%	80,419 $1.33 Million
Q4 2017 Feb 14, 2018	SELL	$12.12 - $21.65 $2.1 Million - $3.76 Million	-173,457 Reduced 63.08%	101,543 $1.92 Million
Q3 2017 Nov 14, 2017	BUY	$11.94 - $14.29 $3.28 Million - $3.93 Million	275,000	275,000 $3.37 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Park West Asset Management LLC with notifications on news.